Denti.AI gains FDA clearance for imaging product

Denti.AI recently earned FDA 510(k) clearance for its artificial intelligence-powered imaging technology.

Advertisement

Denti.AI Detect helps dental professionals identify dental diseases such as caries, periapical lesions and bone loss, according to an Oct. 25 news release. 

The company said it is the first to earn FDA clearance for the detection and presentation of all three dental conditions.

At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.

Advertisement

Next Up in AI and Teledentistry

Advertisement

Comments are closed.